Vitruvian Shield Holding SA incorporated in Épalinges, Switzerland.
About
Building the Infrastructure Layer for Clinical Research
From a biomedical engineering vision to a global clinical trial platform, built with Swiss precision since 2016.
Our Story
Vitruvian Shield was founded in 2016 with a clear conviction: clinical trials shouldn't require patients to organize their lives around clinic visits, and researchers shouldn't drown in fragmented technology stacks just to collect quality data.
What began as a remote patient monitoring research project evolved into something far more ambitious, a unified, API-first platform that connects every layer of clinical trial execution. We asked ourselves: what if clinical trial infrastructure worked like Stripe works for payments? One platform, one data model, every module connected.
Today, Vitruvian Shield unifies CTMS, EDC, eConsent, ePRO, Remote Patient Monitoring, and AI Analytics in a single compliant environment. We offer broad device coverage across clinical grade and consumer wearables, with direct medical grade integrations for continuous ECG, EEG, multi parameter vital signs, and camera based contactless vital sign monitoring via rPPG technology. We have built pre-validated regulatory compliance across ICH E6(R3), GDPR, HIPAA, and FDA 21 CFR Part 11, with active clinical study protocols in ethics preparation across Swiss and Portuguese academic medical centers, and a growing pipeline in oncology, neurology, and chronic disease.
Recognition
Industry awards and recognition received by Vitruvian Shield and its leadership.
European CEO of the Year 2024-2025
Awarded to Paulo Martins for leadership in AI-driven decentralized clinical trial infrastructure.
Portuguese National Innovation Award 2024
For contribution to the national innovation ecosystem.
APDC Health Award, First Place 2025
Awarded by the Portuguese Association for the Development of Communications.
World Summit Awards Portugal 2024 Winner
In the Health and Well-Being category.
Four Entities. One Platform.
Vitruvian Shield operates through four legal entities across Europe, the South Caucasus, and the Middle East.
- LausanneHeadquarters · Vitruvian Shield Holding SA & Vitruvian Shield SA
- AveiroPortuguese subsidiary · Vitruvian Shield PT LDA
- YerevanEngineering centre · Vitruvian Shield AM
- DubaiUAE market entry · Vitruvian Shield FZCO (DMCC)
Company History
Milestones along the path from a biomedical engineering vision to an API-first decentralized clinical trial platform.
Scroll to advance timeline
Platform inception. Remote patient monitoring research evolves into the foundation for a full DCT infrastructure layer.
Portuguese entity established; operations ramp at PCI Creative Science Park, Aveiro.
Armenia engineering centre opened in Yerevan; core platform services scale.
First commercial pilots in preparation with European hospital networks and CROs.
First clinical studies enter activation; dual product lines (RESEARCH + CONNECT) crystallise.
Global Presence
Headquartered in Switzerland. Operating across Europe, the South Caucasus, and the Middle East.
CH
Switzerland
Vitruvian Shield Holding SA (CHE-380.090.655) and Vitruvian Shield SA (CHE-390.132.812). Headquartered at Biopole Life Sciences Campus, Rue de la Corniche 3b, 1066 Epalinges. Platform architecture, regulatory strategy, and business development.
PT
Portugal
Vitruvian Shield PT LDA (NIPC 517508729). Based at PCI Creative Science Park Aveiro Region, Ilhavo. Clinical operations, software development, and clinical trial execution.
AM
Armenia
Vitruvian Shield AM (Reg. 264.110.1489516). Operating from Hakob Hakobyan 3, Mergelyan Institute, Yerevan. Engineering hub for AI/ML, data engineering, and platform infrastructure.
AE
UAE
Vitruvian Shield FZCO (Licence DMCC-945790). Registered at DMCC, Dubai. Market expansion and partnerships with Gulf healthcare systems.
Clinical Study Pipeline
Ongoing and planned clinical research activities across our therapeutic focus areas.
Oncology Electronic Survey Pilot
Oncology electronic survey pilot at a leading Portuguese academic medical center, in ethics preparation for 2026, combining EORTC QLQ-C30 and PRO-CTCAE instruments to capture longitudinal quality-of-life and symptom data in cancer patients.
Multi-Center Epilepsy DCT
Multi-center epilepsy decentralized clinical trial protocol in preparation across Swiss and Portuguese academic sites, using continuous electroencephalography capture and remote patient monitoring.
Chronic Disease Remote Monitoring
Chronic disease remote monitoring pilots under discussion with European academic medical centers.
Leadership
The named executives accountable for platform direction, regulatory posture, engineering, and quality across our four legal entities.
Full team, including engineering, clinical, and strategic advisors, listed below.
Non-Dilutive Capital & Recognition
A diversified, non-dilutive funding base signals capital efficiency and institutional validation.
CHF 375,000+
Research Grants
Innosuisse (Switzerland), Aide Suisse à la Montagne (Switzerland), and ANI (Portugal). Non-dilutive research and innovation funding secured to date.
USD 500,000
Cloud Sponsorships
Microsoft Azure and Google Cloud startup credits supporting platform infrastructure and AI development.
2025-2026
Selo de Idoneidade Científica
Portuguese scientific validity certification, renewed for the 2025-2026 cycle.
Additional financing disclosures are shared privately with qualified investors on request.
Our People
A 25-person team across Switzerland, Portugal, Armenia, and the UAE. Selected members shown below.
Executive Leadership
Clinical and Strategic Advisors
Our Values
The principles that guide every decision we make.
Regulatory Integrity
Compliance isn't a feature, it's the foundation. Every line of code is written with regulatory inspection readiness as a first-class requirement, not an afterthought.
Patient Centricity
Technology should reduce patient burden, not add to it. We design every workflow around the question: does this make the patient's experience better?
Scientific Rigor
Clinical decisions must be grounded in validated data. We build tools that generate evidence you can trust, no shortcuts, no compromises on data integrity.
Speed of Execution
The urgency of clinical research demands velocity. We move fast, ship continuously, and iterate relentlessly, without ever sacrificing quality or compliance.